COMPANY PRESENTATION. We Laser your World

Similar documents
COMPANY PRESENTATION

COMPANY PRESENTATION

COMPANY PRESENTATION. Oct. 21 st, 2015

Company Presentation. BANCA IFIGEST June 24 th, 2011

The Bod of El.En. releases consolidated 2017 six months financial report

The Board of Directors of El.En. Spa releases the draft 2009 financial statements

The Board of Directors of El.En. approves the quarterly financial report as of September 30 th, 2017

The Bod of El.En. releases the consolidated 2018 six months financial report

The Board of Directors of El.En. SpA approves the quarterly financial report as of September 30 th, 2012

Medical Devices EQUITY RESEARCH INDUSTRY UPDATE. Aesthetic Industry Update. Healthcare. Summary. Details

EL.EN. BUY. Lasers Point in the Right Direction. Italian Research New Coverage Milan, July 27, Price (Eu): Target Price (Eu):

EQUITY RESEARCH Update EL.EN. * OUTPERFORM (unchanged)

Q Financial Results (unaudited)

Sisram Medical 1696.HK

Syneron Candela (NASDAQ:ELOS) Investor Presentation May Oppenheimer-Nasdaq Conference Tel Aviv, May 22, Injecting Energy. Changing Lives.

Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies. March 18, 2013

Cutera, Inc. Company Overview

Fidia S.p.A.: the BoD approves the Quarterly Report as at September 30, 2017

: 40 SPARKLING YEARS

1Q 2015 Conference Call

ISAGRO AS OF DECEMBER 31 ST, 2017

Small Caps Opportunity

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers

Company Presentation. Cable Conference. ABN AMRO - London, 10th January 2008

STAR Conference. 6 th October 2016, London

BORSA ITALIANA - STAR segment PRESS RELEASE. INTERIM REPORT AS AT SEPTEMBER 30 th 2017 (in brackets results as at 30/09/2016)

: 40 SPARKLING YEARS. Company profile

Star Conference 2014 London

H Results. H Results

NuVasive, Inc. 34 th Annual J.P. Morgan Healthcare Conference

BORSA ITALIANA - STAR segment PRESS RELEASE

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers

Investors Day. Frankfurt, January 25, 2018

9M 2015 Conference Call

Financial Results Investor Presentation

2014 Results Conference Call. 9 th March, 2015

DJO Global, Inc. Company Presentation. June 2013

ROADSHOW PRESENTATION. March 2010

Fare clic per modificare lo stile del titolo FY 2006 Financial Results

BORSA ITALIANA - STAR segment PRESS RELEASE. INTERIM REPORT AS AT SEPTEMBER 30 th 2018 (in brackets results as at 30/09/2017)

SMA SOLAR TECHNOLOGY AG Analyst / Investor Presentation Quarterly Financial Results: January to March 2014

2017FY - Results presentation. March 21, 2018

Financial Year March 15, Leveraging the Group s Position

1H 2016 Conference Call

1Q2010 Results Presentation. 11th May 2010

Continued strong growth

title 9 Months 2012 title Conference Call 12 th November 2012 date

4Q 2017 Financial Results Conference Call March 6, NASDAQ: MTLS

Itway (ITW.IM) 1H 08/09 results: once again affected by the crisis June 16, 2009

EQUITY RESEARCH Update EL.EN. * IN LINE (from OUTPERFORM)

EQUITY RESEARCH Update EL.EN. * OUTPERFORM (unchanged)

TELECOM ITALIA GROUP. Telecom Italia Group. Investor Meetings Paris, July Franco Bernabè Chairman and Group CEO

BORSA ITALIANA - STAR segment PRESS RELEASE. INTERIM FINANCIAL REPORT AS AT JUNE 30 th 2018 (in brackets results as at 30/06/2017)

ANNUAL SHAREHOLDER MEETING

EQUITY RESEARCH Update EL.EN. * OUTPERFORM (unchanged)

ISAGRO, TODAY. From 2011 turnaround to the growth before us. STAR Conference. Milan, March 28 th, 2012

LA DORIA announces 2014 preliminary consolidated results and Three-Year Plan.

William Blair Growth Stock Conference. June 13, 2012

London STAR Conference

Catalent, Inc. Jefferies Global Healthcare Conference. June 9, DEVELOPMENT DELIVERY SUPPLY more products. better treatments. reliably supplied.

Delivering Sustainable

IR PRESENTATION January 2019

Fidia S.p.A.: the BoD approves the Half Yearly Report as at June 30, 2017

FY 2017 Results STAR Conference

El.En. OUTPERFORM UNCHANGED. Direzione Finanza April 1, 2004

Henkel AG & Co. KGaA. Klaus Keutmann Frankfurt,

Milestone Scientific Reports Second Quarter 2015 Financial Results and Provides Business Update

LEM - Maintaining the Growth Momentum Half year results FY 2006/07

BUY Target: US$ Event. Impact. Action. Maintain BUY rating. Valuation

Forward Looking Statements

Company presentation. Milan - March 24-25, 2015

Mindray Medical International Limited. November 2011

1Q 2013 INVESTOR PRESENTATION

Total Systems Sold to Date

FINANCIAL PRESENTATION. Milan, 15 November 2017

2011 Preliminary Results Conference Call. 9 February, SORIN GROUP Presentation 1

Half Yearly Financial Report as of 30 th June 2015

Mindray Medical International Limited Corporate Presentation

Henkel FY Kasper Rorsted Carsten Knobel. Düsseldorf March 4, 2015

RESEARCH UPDATE. Ready for the American Dream? Fair Value: 4.55 (Prev. 4.50)

Mölnlycke. Investor Capital Markets Day 30 March 2017

1H 2015 Conference Call

1H10 Conference Call. Bologna 30 th July, 2010

1H15 Results Presentation. July 30, 2015

DeA Capital. XXXXXXXXXXX [TITOLO] DeA Capital update. London 1 October 2013 Star Conference

IR PRESENTATION June 2018

FY 2012 Results. March 12 th, 2013

ESTIMATES REVISION. Fair Value: 3.87 (Prev. 3.31) From Brazilian Integration to MTA Migration! Healthcare Goods and Services

DeA Capital. XXXXXXXXXXX [TITOLO] DeA Capital update

Be: Revenues equal to / mln 92.7, 41.8% generated abroad. EBITDA + 5.4% and EBT % vs 9M-2016

Press Release MILAN, MAY 12, 2015 THE BOARD OF DIRECTORS OF DIASORIN S.P.A. APPROVES THE RESULTS FOR THE FIRST QUARTER OF 2015: INCREASE

Henkel company presentation

Q2 and H Results. DIASORIN SPA August 2, 2018

Ellex Medical Lasers. Investor Presentation - Australia for 12 months ended 30 June (23 September 2014)

OUR FY2016 OUR RESULTS. Investor Presentation, 17 March 2017

2009 Nine Months Results. New York 23/24 November 2009

Mindray Medical International Limited

Henkel Our strategic priorities for the future. Hans Van Bylen / Carsten Knobel Press Conference, November 17, 2016

ZEBRA TECHNOLOGIES FIRST QUARTER 2016 RESULTS May 10, 2016

Transcription:

COMPANY PRESENTATION We Laser your World Frankfurt, 25.01.2018

DISCLAIMER Certain statements in this slide show, including those addressing the Company s beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward looking statements. Forward looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward looking statement can be guaranteed and actual future results, performance,orachievementsmay vary materially from those expressed or implied by such forward looking statements. The Company undertakes no obligation about the contents nor to update the forward looking statements to reflect events or circumstances that may arise after the date hereof.

AGENDA 1 The El.En. Group 2 4 3 Our Markets Growth drivers Financial Highlights 5 Multiples & Comparables 3

The El.En. Group 4

Hi Tech company Hi Tech industrial group active in opto electronics with proprietary technologies and know how developed over 35 years International Group More than 20 companies active worldwide on several markets and application segments. Listed on the Milan Stock Exchange, Star segment Among the leaders in the global market Progressively widening its worldwide presence registered continuous growth over the years Worldwide distribution network > 1,200 employees worldwide, more than 40,000 laser sources sold Constant Growth 13% Revenue CAGR 2011 2016 40% EBIT CAGR 2011 2016 The El.En. Group A Primary Player Providing Medical, Industrial, and Conservation Laser Solutions Worldwide FY 2016 Consolidated Revenue at 253m, up 16% YoY, 9M 2017 218m up 22% 5

El.En. Worldwide SALE SUBSIDIARIES PRODUCTION SITES HEADQUARTER 6

Our Strenghts Dynamic R&D activity performed in several centers of excellence Exploiting 35 years of know how Competition through incremental and breakthrough innovations Worldwide presence through a wide network of distributors with direct distribution in selected countries Multi brand approach to maximize penetration in medical markets 7

Our Markets 8

Medical & Aesth energy based systems market US$ million 2014 2016 2021 CAGR 14 16 Key growth drivers: CAGR 16 21 Global non invasive and minimally invasive medical aesthetic treatment systems 6.932 8.437 13.992 10% 11% Energy based treatment systems 2.033 2.670 4.380 15% 10% Body shaping & Skin tightening 724 996 1.965 17% 15% Skin rejuvenation 523 695 1.089 15% 9% Hair removal 353 341 333 2% 0% Leg vein treatments 131 157 187 9% 4% Acne reduction 96 110 125 7% 3% Vaginal rejuvenation na 105 332 na 26% Pigmented lesion & tattoo removal 80 99 142 11% 7% Other 126 167 207 15% 4% Total 2.033 2.670 4.380 15% 10% Source: Medical Insight Report Increasingly aging population Desire to achieve or maintain more youthful appearance Increase in healthcare spending Requirements for fast and minimally invasive surgical procedures 9

Industrial laser market Lasers increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity Sheet metal cutting: technology breakthroughs lead to strong widening of demand Laser marking for identification: traceability as a quality standard Market forecast for high power laser systems: 2016 2020 CAGR 7,6% Source: Optech Consulting 10

Growth drivers 11

Growth drivers Expected growth in our main markets: Aesthetic, Surgery, Industrial Novel body contouring and cellulite treatment device Novel dermatologic treatment device Picosecond tattoo removal lasers: new wavelength and max peak power Broaden indications of use for MonaLisa Touch through extensive clinicals Diabetic foot ulcers: seeking regulatory clearances worldwide >1 kw RF CO 2 laser source launched @ Laser 2017 Strong demand for high power laser sheet metal cutting systems in China and Europe 12

A PATH OF GROWTH Revenues EBIT 137 151 157 Cagr: +14% 180 218 253 300 Cagr: +34% 22 28 30 5 7 10 15 2011 2012 2013 2014 2015 2016 2017e 2011 2012 2013 2014 2015 2016 2017e in Euro million 13

Financial Highlights 14

INCOME STATEMENT 9M 2017 Euro Million 30/09/16 % 30/09/17 % Var.% unaudited unaudited Revenues 179.565 100,0% 218.412 100,0% 21,6% Gross margin 78.623 43,8% 90.899 41,6% 15,6% EBITDA 22.962 12,8% 26.548 12,2% 15,6% EBIT 19.769 11,0% 22.160 10,1% 12,1% Pretax Income 42.027 23,4% 19.108 8,7% 54,5% 31/12/16 30/09/17 unaudited Net financial position 82.784 75.760 15`

CASH FLOW 9M 2017 120.000 100.000 80.000 60.000 40.000 20.000 0 NFP Opening Nopat D&A NWC Other receivables / payables ST Capex Financial&non oper. inc./(exp.) Dividends paid Other adjustments NFP Ending + 16`

9M REVENUE BREAKDOWN BY AREA 2016 +21% 2017 +23% +21% 117 142 33 40 30 36 Italy RoEU RoW in Euro million 17

9M MEDICAL REVENUE BREAKDOWN +22% 9% 18% +17% in Euro million 18

9M INDUSTRIAL REVENUE BREAKDOWN +65% +27% +23% +13% in Euro million 19

2017 GUIDANCE 2016 2017 253 mln SALES 300 mln 27 mln EBIT 30 mln 20

Multiples & Comparables 21

Multiples Stockholder's Equity per share 9,6 Price / Book Value Adj. 2,8 EV /EBIT (80% EBIT) 17,9 EV / Sales (80% Sales) 1,8 El.En. Market Cap. 510,2 @ 26,44 Net financial position 75,8 @ 30/09/17 Financial investments m/l term 12,0 @ 30/09/17 Enterprise Value 422,5 22

Comparables Amounts in mln Sept. 30th, 2017 Medical/Aesthetic Price Revenue Var.% Rev. EBIT EBIT % MK.Cap. EV EV/Sales (*) EV/EBIT (*) Cash Adj. P/E (*) P/Book Value Cutera $49,50 $104 30% $7 6% $693 $642 4,6 73,8 67,7 11,3 Biolase $0,53 $34 10% $(13) 39% $40 $36 0,8 n.a. n.a. 1,9 Sisram Medical (**) $0,86 $66 13% $14 21% $379 $392 3,0 13,8 25,1 7,8 Industrial IPG Photonics Co. $260,97 $1.048 44% $403 38% $14.048 $13.006 9,3 24,2 33,1 7,2 Prima Industrie 38,15 300 9% 17 6% 400 503 1,3 22,2 31,1 2,8 Han's Laser 51,93 8.915 42% 1.573 18% 55.418 53.907 4,5 25,7 26,9 8,0 El.En. (1) 26,44 218 22% 22 10% 510 423 1,8 17,9 30,0 2,8 (1) EV and multiplies as for previous slide (*) Revenue,Ebit and earnings annualized (**) Data as at June 30 th. 2017 23

Contacts El.En. SPA Enrico ROMAGNOLI Investor Relations Manager tel. +39 055 8826807 E mail: finance@elen.it POLYTEMS HIR Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI b.fersini@polytemshir.it s.marongiu@polytemshir.it Tel. +39 06 69923324